Evidence map›Paper›PMID 39281464›Full record

ReviewHeliyon2024

Unveiling the future: Bibliometric analysis on the application of nanomaterials in osteoarthritis (2006-2023).

Chunxi Shu, Xinyang Yin, Qin Zhong, Ming Cheng

Abstract readReview
In one paragraph

Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chunxi ShuDepartment of Sports Medicine, Orthopaedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, China.
Xinyang YinDepartment of Sports Medicine, Orthopaedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, China.
Qin ZhongDepartment of Sports Medicine, Orthopaedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, China.
Ming ChengDepartment of Sports Medicine, Orthopaedic Hospital, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: As the population ages, the socio-economic impact of osteoarthritis (OA) is becoming increasingly significant. In recent years, there has been a growing focus on the design and development of nanomaterials for diagnosing and treating OA. This study aims to comprehensively evaluate the current status and trends in the application of nanomaterials in OA through bibliometric analysis and provide a review. Methods: Studies on nanomaterials and OA were sourced from the Web of Science Core Collection (WoSCC) database, with relevant articles selected based on predefined inclusion criteria. Quantitative and visual analyses of the included publications were conducted using tools such as VOSviewer, and GraphPad Prism 9.5.0. Results: A total of 532 publications were included in this study. The number of annual publications has increased steadily from 2006 to 2023. China, the United States, and South Korea are the leading countries in this field. Shanghai Jiao Tong University and Li Zheng are recognized as the most influential institutions and authors, respectively. Biomaterials is the most frequently published and cited journal. Current research primarily focuses on drug delivery and the anti-inflammatory and antioxidant properties of nanomaterials. Recent research hotspots include mesoporous silica nanoparticles, electrostatic interaction, and injectable hydrogels. Conclusion: In this study, we summarised the annual publication trends and identified the most influential countries, institutions, authors, journals, and current research and development trends in the application of nanomaterials for OA.

Indexed as

Bibliometric analysisNanomaterialOsteoarthritisResearch trend

Identifiers

PMID39281464
PMCPMC11400977

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.